Design, Synthesis, and Validation of a Novel [11C]Promethazine PET Probe for Imaging Abeta Using Autoradiography

Molecules. 2021 Apr 10;26(8):2182. doi: 10.3390/molecules26082182.

Abstract

Promethazine, an antihistamine drug used in the clinical treatment of nausea, has been demonstrated the ability to bind Abeta in a transgenic mouse model of Alzheimer's disease. However, so far, all of the studies were performed in vitro using extracted tissues. In this work, we report the design and synthesis of a novel [11C]promethazine PET radioligand for future in vivo studies. The [11C]promethazine was isolated by RP-HPLC with radiochemical purity >95% and molar activity of 48 TBq/mmol. The specificity of the probe was demonstrated using human hippocampal tissues via autoradiography.

Keywords: Abeta; Alzheimer; PET imaging; autoradiography; promethazine.

MeSH terms

  • Alzheimer Disease / diagnosis*
  • Alzheimer Disease / diagnostic imaging
  • Alzheimer Disease / pathology
  • Animals
  • Autoradiography
  • Brain / diagnostic imaging*
  • Brain / drug effects
  • Humans
  • Mice
  • Plaque, Amyloid / diagnosis
  • Plaque, Amyloid / diagnostic imaging
  • Plaque, Amyloid / pathology
  • Positron-Emission Tomography
  • Promethazine / chemical synthesis
  • Promethazine / chemistry
  • Promethazine / pharmacology*
  • Radiochemistry
  • Radiopharmaceuticals / chemical synthesis
  • Radiopharmaceuticals / chemistry
  • Radiopharmaceuticals / pharmacology*

Substances

  • Radiopharmaceuticals
  • Promethazine